Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Dtg Art'

Dtg Art published presentations and documents on DocSlides.

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

  • luanne-stotts
  • 31 Slides

Progressive rises in weight and clinical obesity ...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

  • iris
  • 11 Slides

ADVANCE. . Design. Primary endpoint. Proportion ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

  • kylo
  • 31 Slides

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

DTG-Based Regimens Are Active in INI-Naive Patients With a

DTG-Based Regimens Are Active in INI-Naive Patients With a

  • trish-goza
  • 14 Slides

Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

  • lam
  • 10 Slides

Endpoints. Primary: proportion of patients with HI...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

  • winnie
  • 12 Slides

by Baseline NRTI Resistance . and Second-Line NRTI...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

  • jacey
  • 17 Slides

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

  • mitsue-stanley
  • 0 Slides

Data . from other . cohorts and . regions to guid...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

  • aaron
  • 0 Slides

2. Instituto Nacional de Ciencias Médicas y Nutr...

New regimen for $75 a year

New regimen for $75 a year

  • tawny-fly
  • 0 Slides

New pricing agreement will speed up access to gen...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

  • trish-goza
  • 15 Slides

1 Queen Mary University, London, United Kingdom; ...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

  • mediumgeneral
  • 12 Slides

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

  • mediumgeneral
  • 10 Slides

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

WHO ARV Forecasting Meeting

WHO ARV Forecasting Meeting

  • sistertive
  • 31 Slides

Geneva, March 19 - 20 , 2015 1 | Treatment and C...

HIV History successes and lessons learned

HIV History successes and lessons learned

  • linda
  • 13 Slides

PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...

Clinical considerations for the

Clinical considerations for the

  • helene
  • 21 Slides

introduction . of . DTG. Nandita Sugandhi. ICAP at...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

  • brown
  • 34 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

  • audrey
  • 43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

  • deena
  • 32 Slides

Pedro Cahn. Disclosures. Advisory. . boards. : Me...

The Fast and The Continuous:

The Fast and The Continuous:

  • bery
  • 18 Slides

Dolutegravir-based Antiretroviral Therapy Achieves...

Emergence of resistance in

Emergence of resistance in

  • emma
  • 1 Slides

HIV-1 Integrase . following dolutegravir (DTG) tre...

Basic HIV Course for Health Professionals

Basic HIV Course for Health Professionals

  • megan
  • 13 Slides

Session 12: Contraceptives and HIV. Learning Objec...

Antiretrovirals for prevention in women of childbearing age:

Antiretrovirals for prevention in women of childbearing age:

  • tremblay
  • 30 Slides

issues to consider. Landon Myer. We all have “is...

Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store

Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store

  • 3vprintingstore
  • 100 Slides

In the bustling city of Atlanta, fashion-forward i...

JM Llibre , 1 C-C Hung,

JM Llibre , 1 C-C Hung,

  • mohammad106
  • 16 Slides

2. C Brinson,. 3. F Castelli,. 4. P-M Girard,. ...

Gyroscope

Gyroscope

  • conchita-marotz
  • 23 Slides

By: Wang Po En(3o3). Definition. History. Physics...

ser DTG Activity location Dress Responsibility remarks

ser DTG Activity location Dress Responsibility remarks

  • tatyana-admore
  • 100 Slides

Friday 08 Aug 14 2 1700-2300hrs Welcome fun...

ID Week 2016: HIV Update

ID Week 2016: HIV Update

  • min-jolicoeur
  • 25 Slides

Robert Harrington, M.D.. ID Week 2016: HIV Update...

Toll free in USA: 877.626.2538

Toll free in USA: 877.626.2538

  • natalia-silvester
  • 42 Slides

Where to Start?. Launching or adding a DTG line o...

Face Recognition based on 2D-PCA and CNN

Face Recognition based on 2D-PCA and CNN

  • alida-meadow
  • 11 Slides

. hongliang. . xue. Motivation. . ...

Toll free in USA: 877.626.2538

Toll free in USA: 877.626.2538

  • ellena-manuel
  • 42 Slides

Where to Start?. Launching or adding a DTG line o...

IMPAACT 2010 Pharmacy, Study Drug, and Concomitant Medication Considerations at Entry

IMPAACT 2010 Pharmacy, Study Drug, and Concomitant Medication Considerations at Entry

  • pamella-moone
  • 0 Slides

Protocol References. Section. Title. 6.2. Entry V...

RUNNING ESTIMATE I. GATHER FACTS AND ASSUMPTIONS: (The UMT gathers information concerning the assig

RUNNING ESTIMATE I. GATHER FACTS AND ASSUMPTIONS: (The UMT gathers information concerning the assig

  • yoshiko-marsland
  • 0 Slides

(PAGE 1 OF 5). UNIT: DTG: EVENT: . FACTS ON....

Dual Antiretroviral Therapy

Dual Antiretroviral Therapy

  • debby-jeon
  • 0 Slides

This program will include a discussion of off-lab...

Copyright © 2024 DocSlides. All Rights Reserved